We are live on ! Find out more
E

Ergoteles Portfolio holdings

AUM $68.2M
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+7.33%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
10 Year Est. Return
AUM
$4.36B
AUM Growth
+$1.15B
Cap. Flow
+$991M
Cap. Flow %
22.7%
Top 10 Hldgs %
14.65%
Holding
1,807
New
1,048
Increased
148
Reduced
170
Closed
353

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$66.5M
2
XOM icon
ExxonMobil
XOM
+$54.9M
3
AAPL icon
Apple
AAPL
+$52.1M
4
HMSY
HMS Holdings Corp.
HMSY
+$48.4M
5
ORCL icon
Oracle
ORCL
+$42.3M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Healthcare 14.66%
3 Consumer Discretionary 14.56%
4 Financials 10.08%
5 Industrials 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIGA icon
1351
SIGA Technologies
SIGA
$223M
$143K ﹤0.01%
+22,700
New +$156K
MBI icon
1352
MBIA
MBI
$288M
$142K ﹤0.01%
12,900
-35,100
-73% -$350K
PGRWU
1353
DELISTED
Progress Acquisition Corp. Units
PGRWU
$142K ﹤0.01%
14,180
SDACU
1354
DELISTED
Sustainable Development Acquisition I Corp. Unit
SDACU
$140K ﹤0.01%
13,800
IBER.U
1355
DELISTED
Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U
$139K ﹤0.01%
13,850
DSSI
1356
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
$138K ﹤0.01%
13,820
-29,230
-68% -$303K
NRACU
1357
DELISTED
Northern Revival Acquisition Corporation Unit
NRACU
$138K ﹤0.01%
13,805
FNB icon
1358
FNB Corp
FNB
$6.78B
$136K ﹤0.01%
+11,000
New +$143K
EVOJU
1359
DELISTED
Evo Acquisition Corp. Unit
EVOJU
$133K ﹤0.01%
13,216
NAGE
1360
Niagen Bioscience
NAGE
$256M
$132K ﹤0.01%
+13,400
New +$117K
KDMN
1361
DELISTED
Kadmon Holdings, Inc.
KDMN
$132K ﹤0.01%
+34,100
New +$132K
MSAC
1362
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$131K ﹤0.01%
+13,580
New +$133K
ADVM
1363
DELISTED
Adverum Biotechnologies
ADVM
$130K ﹤0.01%
+3,720
New +$200K
CBUS icon
1364
Cibus
CBUS
$130M
$128K ﹤0.01%
+636
New +$151K
TISI icon
1365
Team
TISI
$77.7M
$127K ﹤0.01%
+1,890
New +$172K
MACQU
1366
DELISTED
MCAP Acquisition Corporation Unit
MACQU
$127K ﹤0.01%
12,700
GHACU
1367
DELISTED
Gaming & Hospitality Acquisition Corp. Unit
GHACU
$126K ﹤0.01%
12,623
FNHC
1368
DELISTED
FedNat Holding Company Common Stock
FNHC
$126K ﹤0.01%
+30,400
New +$137K
VTVT icon
1369
vTv Therapeutics
VTVT
$121M
$124K ﹤0.01%
+1,355
New +$137K
PRPC.U
1370
DELISTED
CC Neuberger Principal Holdings III Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
PRPC.U
$123K ﹤0.01%
12,300
CRD.A icon
1371
Crawford & Co Class A
CRD.A
$536M
$122K ﹤0.01%
+13,462
New +$133K
TCRT icon
1372
Alaunos Therapeutics
TCRT
$4.74M
$121K ﹤0.01%
+305
New +$142K
HIIIU
1373
DELISTED
Hudson Executive Investment Corp. III Unit
HIIIU
$121K ﹤0.01%
12,100
BBLN
1374
DELISTED
Babylon Holdings Limited
BBLN
$120K ﹤0.01%
+485
New +$119K
EJFAU
1375
DELISTED
EJF Acquisition Corp. Unit
EJFAU
$119K ﹤0.01%
11,900

Similar funds

Ergoteles's Q2 2021 Portfolio in Review

As of Q2 2021, Ergoteles held 1,807 positions worth $4.36B, up 36% from $3.21B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Ergoteles deployed $991M of net new capital in Q2 2021, opening 1,048 new positions and adding to 148 existing holdings. Its largest new stake was Linde: 174,841 shares worth $50.5M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Walt Disney, an estimated $66.5M trimmed.

  • Ergoteles's largest Q2 2021 buy was Linde: 174,841 shares worth $50.5M.
  • Ergoteles added most to PRA Health Sciences, Inc. in Q2 2021, an estimated $160M increase.
  • Ergoteles's biggest Q2 2021 reduction was Walt Disney, cutting an estimated $66.5M.
  • Ergoteles fully exited ExxonMobil in Q2 2021, selling an estimated $54.9M.
  • Ergoteles's ten largest holdings make up 15% of its $4.36B portfolio in Q2 2021.
  • Ergoteles opened 1,048 new positions and closed 353 in Q2 2021.
  • Ergoteles's portfolio value rose 36% quarter-over-quarter to $4.36B.

Based on Ergoteles's 13F filing for Q2 2021, filed 12 Aug 2021.